Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER –Medicare Cohort

We used the Surveillance, Epidemiology, and End Results (SEER) –Medicare-linked database to characterize the patterns of presentation, treatment, and survival in older diffuse large B-cell lymphoma (DLBCL) patients with concomitant autoimmune disease. DLBCL patients with autoimmune disease were more likely to be female but otherwise did not differ significant ly from other DLBCL patients in demographic data, treatment, or clinical outcomes.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research